Low-dose ketamine analgesia: Patient and physician experience in the ED

John R Richards, Rachel E. Rockford

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective: Low-dose ketamine (LDK) may be useful for treatment for opioid-tolerant patients. We conducted a survey of patients and their treating clinicians regarding LDK for analgesia. Methods: Survey data included the following: vital signs and pain score before and after LDK, demographics, and adverse effects. Treating physicians were queried about reasons for use of LDK and overall satisfaction. Results: Twenty-four patients were enrolled: 21 received LDK for analgesia, and 3 received LDK for sedation. Pain level on a visual analog scale (range, 1-10) after LDK was significantly decreased from 8.9 ± 2.1 to 3.9 ± 3.4 (P <.0001). Change in vital signs after administration of LDK was not statistically significant. Overall patient satisfaction with LDK was 55%, and overall physician satisfaction was 72%. Sixteen (67%) of patients would prefer LDK again, and 23 (96%) of physicians would use LDK again for analgesia. Four patients reported an adverse experience, but there were no emergence reactions. Race subanalysis revealed no difference in pain reduction, but whites were least satisfied compared with black and Hispanic patients (P =.02). Physician reasons for using LDK included opioid failure (88%), concern for respiratory depression (17%), concern for multiple opioid allergies (13%), and concern for hypotension (8%). Most (96%) physicians believed that LDK is underused. Conclusion: Low-dose ketamine may decrease patients' perception of pain. Most were satisfied with LDK for this purpose and would use it again. Whites were least satisfied with the use of LDK for analgesia. Physicians believed that ketamine is underused.

Original languageEnglish (US)
Pages (from-to)390-394
Number of pages5
JournalAmerican Journal of Emergency Medicine
Volume31
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Ketamine
Analgesia
Physicians
Opioid Analgesics
Vital Signs
Pain
Pain Perception
Visual Analog Scale
Patient Satisfaction
Hispanic Americans
Respiratory Insufficiency
Hypotension

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Low-dose ketamine analgesia : Patient and physician experience in the ED. / Richards, John R; Rockford, Rachel E.

In: American Journal of Emergency Medicine, Vol. 31, No. 2, 02.2013, p. 390-394.

Research output: Contribution to journalArticle

@article{98317a2506e84c9a904c1583ada2dc2c,
title = "Low-dose ketamine analgesia: Patient and physician experience in the ED",
abstract = "Objective: Low-dose ketamine (LDK) may be useful for treatment for opioid-tolerant patients. We conducted a survey of patients and their treating clinicians regarding LDK for analgesia. Methods: Survey data included the following: vital signs and pain score before and after LDK, demographics, and adverse effects. Treating physicians were queried about reasons for use of LDK and overall satisfaction. Results: Twenty-four patients were enrolled: 21 received LDK for analgesia, and 3 received LDK for sedation. Pain level on a visual analog scale (range, 1-10) after LDK was significantly decreased from 8.9 ± 2.1 to 3.9 ± 3.4 (P <.0001). Change in vital signs after administration of LDK was not statistically significant. Overall patient satisfaction with LDK was 55{\%}, and overall physician satisfaction was 72{\%}. Sixteen (67{\%}) of patients would prefer LDK again, and 23 (96{\%}) of physicians would use LDK again for analgesia. Four patients reported an adverse experience, but there were no emergence reactions. Race subanalysis revealed no difference in pain reduction, but whites were least satisfied compared with black and Hispanic patients (P =.02). Physician reasons for using LDK included opioid failure (88{\%}), concern for respiratory depression (17{\%}), concern for multiple opioid allergies (13{\%}), and concern for hypotension (8{\%}). Most (96{\%}) physicians believed that LDK is underused. Conclusion: Low-dose ketamine may decrease patients' perception of pain. Most were satisfied with LDK for this purpose and would use it again. Whites were least satisfied with the use of LDK for analgesia. Physicians believed that ketamine is underused.",
author = "Richards, {John R} and Rockford, {Rachel E.}",
year = "2013",
month = "2",
doi = "10.1016/j.ajem.2012.07.027",
language = "English (US)",
volume = "31",
pages = "390--394",
journal = "American Journal of Emergency Medicine",
issn = "0735-6757",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Low-dose ketamine analgesia

T2 - Patient and physician experience in the ED

AU - Richards, John R

AU - Rockford, Rachel E.

PY - 2013/2

Y1 - 2013/2

N2 - Objective: Low-dose ketamine (LDK) may be useful for treatment for opioid-tolerant patients. We conducted a survey of patients and their treating clinicians regarding LDK for analgesia. Methods: Survey data included the following: vital signs and pain score before and after LDK, demographics, and adverse effects. Treating physicians were queried about reasons for use of LDK and overall satisfaction. Results: Twenty-four patients were enrolled: 21 received LDK for analgesia, and 3 received LDK for sedation. Pain level on a visual analog scale (range, 1-10) after LDK was significantly decreased from 8.9 ± 2.1 to 3.9 ± 3.4 (P <.0001). Change in vital signs after administration of LDK was not statistically significant. Overall patient satisfaction with LDK was 55%, and overall physician satisfaction was 72%. Sixteen (67%) of patients would prefer LDK again, and 23 (96%) of physicians would use LDK again for analgesia. Four patients reported an adverse experience, but there were no emergence reactions. Race subanalysis revealed no difference in pain reduction, but whites were least satisfied compared with black and Hispanic patients (P =.02). Physician reasons for using LDK included opioid failure (88%), concern for respiratory depression (17%), concern for multiple opioid allergies (13%), and concern for hypotension (8%). Most (96%) physicians believed that LDK is underused. Conclusion: Low-dose ketamine may decrease patients' perception of pain. Most were satisfied with LDK for this purpose and would use it again. Whites were least satisfied with the use of LDK for analgesia. Physicians believed that ketamine is underused.

AB - Objective: Low-dose ketamine (LDK) may be useful for treatment for opioid-tolerant patients. We conducted a survey of patients and their treating clinicians regarding LDK for analgesia. Methods: Survey data included the following: vital signs and pain score before and after LDK, demographics, and adverse effects. Treating physicians were queried about reasons for use of LDK and overall satisfaction. Results: Twenty-four patients were enrolled: 21 received LDK for analgesia, and 3 received LDK for sedation. Pain level on a visual analog scale (range, 1-10) after LDK was significantly decreased from 8.9 ± 2.1 to 3.9 ± 3.4 (P <.0001). Change in vital signs after administration of LDK was not statistically significant. Overall patient satisfaction with LDK was 55%, and overall physician satisfaction was 72%. Sixteen (67%) of patients would prefer LDK again, and 23 (96%) of physicians would use LDK again for analgesia. Four patients reported an adverse experience, but there were no emergence reactions. Race subanalysis revealed no difference in pain reduction, but whites were least satisfied compared with black and Hispanic patients (P =.02). Physician reasons for using LDK included opioid failure (88%), concern for respiratory depression (17%), concern for multiple opioid allergies (13%), and concern for hypotension (8%). Most (96%) physicians believed that LDK is underused. Conclusion: Low-dose ketamine may decrease patients' perception of pain. Most were satisfied with LDK for this purpose and would use it again. Whites were least satisfied with the use of LDK for analgesia. Physicians believed that ketamine is underused.

UR - http://www.scopus.com/inward/record.url?scp=84873624607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873624607&partnerID=8YFLogxK

U2 - 10.1016/j.ajem.2012.07.027

DO - 10.1016/j.ajem.2012.07.027

M3 - Article

C2 - 23041484

AN - SCOPUS:84873624607

VL - 31

SP - 390

EP - 394

JO - American Journal of Emergency Medicine

JF - American Journal of Emergency Medicine

SN - 0735-6757

IS - 2

ER -